|
|
|
Corporate Profile: Exelixis
Pharmaceuticals
| Summary: |
Exelixis
is a biopharmaceutical
company whose mission is to identify novel therapeutic
targets for drug discovery by elucidating the biochemical
pathways involved in human diseases. |
| Address (HQ):
|
210 East Grand Avenue
South San Francisco, CA 94080 |
| Phone
#'s (HQ): |
Main |
(650) 837-7000 |
| Human Resources |
not known |
| Investor Relations |
(650) 837-7000 |
| Fax
#'s (HQ): |
Main |
(650) 837-8300 |
| Human Resources |
(650) 837-7226 |
| Investor Relations |
(650) 825-2205 |
| Financial
information: |
| EXEL |
| Issued United States patents: |
Issued U.S. patents 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
